New Trends in the Regulation of Biomedical Research in Japan : From Differentiation to Integration?(Academic Society and Research Trend Feature)
-
- TASHIRO Shimon
- 東京大学大学院医学系研究科
Bibliographic Information
- Other Title
-
- 医学研究規制政策の新たな展開 : 分裂から統合へ?(<学会・研究動向特集>制度・政策の現在において問う)
- 医学研究規制政策の新たな展開--分裂から統合へ?
- イガク ケンキュウ キセイ セイサク ノ アラタ ナ テンカイ ブンレツ カラ トウゴウ エ
Search this article
Abstract
Governmental regulations and external review mechanisms for biomedical research were introduced in Japan in the late 1980s. However, there are two major problems yet to be overcome: 1) lack of a clear definition of research and 2) inconsistency among regulations for the protection of participating human subjects. In this paper, I discuss these two problems referring to the recent development of administrative guidelines over biomedical research in Japan. Regarding the former, the 2007 version of the Guidelines for Epidemiological Research introduced a standard for the distinction between research and medical practice. However it does not tell us how the gray zone between research and practice should be regulated. Regarding the latter, the 2008 version of the Guidelines for Clinical Research introduced a stricter regulation for those clinical trials which use already approved drugs or medical devices. Although these new guidelines lead to more consistent regulations, there is still a significant difference among guidelines regarding their binding powers.
Journal
-
- The Japanese Journal of Health and Medical Sociology
-
The Japanese Journal of Health and Medical Sociology 21 (1), 32-38, 2010
The Japanese Society of Health and Medical Sociology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204480661888
-
- NII Article ID
- 110009841530
-
- NII Book ID
- AN10421975
-
- ISSN
- 21898642
- 13430203
-
- NDL BIB ID
- 10897917
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed